Femasys Inc. Files 8-K: Material Agreement, Equity Sales
Ticker: FEMY · Form: 8-K · Filed: Jun 2, 2025 · CIK: 1339005
| Field | Detail |
|---|---|
| Company | Femasys Inc (FEMY) |
| Form Type | 8-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, financial-reporting
TL;DR
Femasys Inc. dropped an 8-K on 5/29 covering a big deal, equity sales, and financials.
AI Summary
On May 29, 2025, Femasys Inc. filed an 8-K report detailing a material definitive agreement, unregistered sales of equity securities, and financial statements. The company, incorporated in Delaware with its principal executive offices in Suwanee, GA, operates in the surgical and medical instruments and apparatus sector.
Why It Matters
This filing provides crucial updates on Femasys Inc.'s financial activities and significant contractual agreements, which could impact investor decisions and the company's operational trajectory.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and unregistered sales of equity, which can introduce financial and regulatory risks.
Key Numbers
- 001-40492 — SEC File Number (Identifies Femasys Inc.'s filing with the SEC.)
- 11-3713499 — EIN (Employer Identification Number for Femasys Inc.)
Key Players & Entities
- Femasys Inc. (company) — Registrant
- May 29, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Suwanee, GA (location) — Principal Executive Offices
- 3841 (sic_code) — Standard Industrial Classification for Surgical & Medical Instruments & Apparatus
FAQ
What is the nature of the material definitive agreement reported?
The filing indicates an 'Entry into a Material Definitive Agreement' as an item of disclosure, but the specific details of the agreement are not provided in this excerpt.
What type of equity securities were sold unregistered?
The filing lists 'Unregistered Sales of Equity Securities' as a reported item, but the specific details regarding the type and amount of securities are not included in this summary.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on May 29, 2025.
Where are Femasys Inc.'s principal executive offices located?
Femasys Inc.'s principal executive offices are located at 3950 Johns Creek Court, Suite 100, Suwanee, GA 30024.
What is Femasys Inc.'s Standard Industrial Classification code?
Femasys Inc.'s Standard Industrial Classification code is 3841, which corresponds to 'Surgical & Medical Instruments & Apparatus'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 2, 2025 regarding FEMASYS INC (FEMY).